EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy

Zhipeng Diao, Hongmei Yu, Yapeng Wu, Yuanbo Sun, Haitao Tang, Mei Wang, Nan Li, Haitao Ge, Jianguo Sun, Harvest F Gu

Frontiers in Pharmacology · 08.01.2024 · 14

DOI: 10.3389/fphar.2023.1290868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.01.2024. Verfasst von Zhipeng Diao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, Research Unit of PK-PD Based Bioactive Components and Pharmacodynamic Targ…. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Huangkui capsule (HKC) is made from the ethanol extract of Abelmoschus manihot (L.) Medik [Malvaceae; abelmoschi corolla] and received approval from the China Food and Drug Administration (Z19990040) in 1999. Currently, HKC is used for treatment of the patients with diabetic nephropathy (DN) in China. The bioactive chemical constituents in HKC are total flavonoids of A. manihot (L.) Medik (TFA). The present study aims to identify the primary flavonoid metabolites in HKC and TFA and their metabolism fates in db/db mice, the animal model for the study of type 2 diabetes and DN.

Methods

HKC (0.84 g/kg/d) and TFA (0.076 g/kg/d) or vehicle were respectively administered daily via oral gavage in db/db mice for 4 weeks. The metabolism fate of the main metabolites of HKC in serum, liver, kidney, heart, jejunum, colon, jejunal contents, colonic contents, and urine of db/db mice were analyzed with a comprehensive metabolite identification strategy. Results and Discussion: In db/db mice administered with HKC and TFA, 7 flavonoid prototypes and 38 metabolites were identified. The related metabolic pathways at Phases I and II reactions included dehydroxylation, deglycosylation, hydrogenation, methylation, glucuronidation, sulphation, and corresponding recombined reactions. Quercetin, isorhamnetin, quercetin sulphate, quercetin monoglucuronide, and isorhamnetin monoglucuronide presented a high exposure in the serum and kidney of db/db mice. Thereby, the present study provides a pharmacodynamic substance basis for better understanding the mechanism of A. manihot (L.) Medik for medication of DN.

Schlagwörter

Stichwörter der Autor:innen

Abelmoschus manihot (L.) medikHPLC-Q-TOF-MS/MSdiabetic nephropathyflavonoidsmetabolismpharmacological mechanism

Autor:innen und Institutionen

  • Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, Research Unit of PK-PD Based Bioactive Components and Pharmacodynamic Target Discovery of Natural Medicine of Chinese Academy of Medical Science…
  • Laboratory of Molecular Medicine, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
  • Suzhong Pharmaceutical Research Institute, Nanjing, China.
  • Department of Endocrinology, Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

Zitieren

APA

Diao, Z., Yu, H., Wu, Y., Sun, Y., Tang, H., Wang, M., Li, N., Ge, H., Sun, J., & Gu, H. F. (2024). Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1290868

Vancouver

Diao Z, Yu H, Wu Y, Sun Y, Tang H, Wang M, et al. Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy. Frontiers in Pharmacology. 2024;14. doi:10.3389/fphar.2023.1290868

BibTeX
@article{Diao2024,
  author = {Diao, Zhipeng and Yu, Hongmei and Wu, Yapeng and Sun, Yuanbo and Tang, Haitao and Wang, Mei and Li, Nan and Ge, Haitao and Sun, Jianguo and Gu, Harvest F},
  title = {Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fphar.2023.1290868}
}
Kostenlos starten →